POS0672 FIRST-IN-HUMAN STUDY OF GS-5718, AN ORAL IRAK-4 INHIBITOR, IN HEALTHY SUBJECTS: PHARMACOKINETICS, SAFETY, TOLERABILITY, AND ASSESSMENT OF EFFECT OF FOOD AND ACID REDUCING AGENTS ON EXPOSURE - Anderson, K.; Hsueh, C.H.; Gurtovaya, O.; Mathur, A.; Taylor, J.; Serone, A.; Othman, A.A. (Annals of the rheumatic diseases, 2021)